1. Events
  2. Policymaker Event

Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Today

SWHR Policy Advisory Council Meeting

Virtual Meeting

SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]

ORWH GENDER R25: Technical Assistance Webinar

Virtual Event

The Office of Research on Women’s Health (ORWH)  is pleased to announce a new program, Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) R25 (RFA-OD-22-015). The […]

Narcolepsy & Women’s Health: A Wake-Up Call

Virtual Event

SWHR hosted a webinar to share educational information about narcolepsy, including diagnosing, treating, and managing care, and to highlight the experiences of women living with narcolepsy.

SWHR Policy Advisory Council Meeting

Virtual Meeting

SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]

Addressing Concerns and Considerations Surrounding the Inclusion of Pregnant and Lactating Populations in Research

Virtual Event

During this virtual congressional briefing and national webinar, panelists reviewed ethical considerations surrounding inclusion of pregnant and lactating women in research, how to ensure the appropriate inclusion of these populations, and the current state of this type of inclusion in research, both within the federal government and the corporate sector.

Friends of ORWH Congressional Reception

Rayburn House Office Building 45 Independence Ave SW, Washington, DC, United States

The Friends of the Office of Research on Women’s Health invite you to a congressional reception in celebration of Women’s […]

Coverage and Access Issues Affecting Women Living with Autoimmune Diseases

Virtual Event

In this webinar, panelists reviewed coverage and access issues that could negatively affect those with autoimmune diseases and conditions, the tenants of prior authorization and step therapy, discuss the role these policies can play in patient outcomes and on providers, and how current policies could be modified to better serve individuals.